Adaptive Biotechnologies Corporation Common StockLive Price
$6.40 USDDecember 20, 2024, 11:15 pm UTC Add to Watchlist Create Price Alert
Adaptive Biotechnologies Corporation Common Stock (ADPT) - Live Price
Adaptive Biotechnologies Corporation Common Stock
Adaptive Biotechnologies Corporation Common Stock (ADPT) is a innovative biotechnology company focused on developing and commercializing advanced diagnostic solutions and immunotherapies for various diseases. Founded in 2008, the company has rapidly gained recognition for its expertise in T-cell receptor (TCR) technology and its ability to create personalized cancer treatments. ADPT's TCR platform enables the company to analyze an individual's immune system and identify unique, potentially effective T-cells for use in immunotherapy treatments. By harnessing the power of the immune system, Adaptive Biotechnologies aims to revolutionize the way diseases are diagnosed and treated. With a strong pipeline of products in development and a growing presence in the biotech industry, ADPT's stock offers promising potential for investors seeking to capitalize on the rapidly evolving world of personalized medicine and immunotherapies.
Get Adaptive Biotechnologies Corporation Common Stock Price Change Alerts
Verdasi can notify you when ADPT goes up or down. Get a text message or email when Adaptive Biotechnologies Corporation Common Stock changes in price.
Setup ADPT Price AlertsHow Many People are employed by Adaptive Biotechnologies Corp.?
How are Adaptive Biotechnologies Corporation Common Stock divided?
Approximately 34.23% of Adaptive Biotechnologies Corporation Common Stock are owned by individual stakeholders. Mutual Funds actively invest in Adaptive Biotechnologies Corp., controlling roughly 29.48% of all Adaptive Biotechnologies Corporation Common Stock.
- Individual Stakeholders: 34.23%
- Mutual Fund: 29.48%
- Other Institutions: 0.00%
How much is Adaptive Biotechnologies Corporation Common Stock stock worth?
Adaptive Biotechnologies Corporation Common Stock (ADPT) is worth $6.40 USD as of December 20, 2024, 11:15 pm UTC time.
View the interactive graph to see how much Adaptive Biotechnologies Corporation Common Stock has changed in the last hour or historically.
Keep learning about stocks:
Have you wondered what a day trader is? Understand the strategies behind day trading, and how professionals traders make their living as a day trader.
When placing your trades, commissions can cut into your expected returns if you're not diligent about minimizing or eliminating trading fees entirely. Learn how!
Day trading has never been more accessible as a Canadian, with no minimum requirements, and the introduction of commission free trades. Learn how to day trade in Canada.